RecruitingNot ApplicableNCT04506853

Single-Sided Deafness and Asymmetric Hearing Loss

Single-Sided Deafness and Asymmetric Hearing Loss Post-Approval Study


Sponsor

Med-El Corporation

Enrollment

65 participants

Start Date

Feb 22, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.


Eligibility

Min Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MED-EL Cochlear Implant System for people with hearing loss, sensorineural and hearing loss, unilateral. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 5 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMED-EL Cochlear Implant System

Cochlear implant and audio processor


Locations(6)

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

University of Iowa

Iowa City, Iowa, United States

New York Eye and Ear Infirmary

New York, New York, United States

University of North Carolina

Chapel Hill, North Carolina, United States

Virginia Mason Medical Center

Seattle, Washington, United States

Sunnybrook Health Sciences Center

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04506853


Related Trials